Concepedia

Anna Mikolajczak

AM

Statistics

Publications

5

Citations

100

H-Index

5

Active since

2021

Affiliations

The Francis Crick Institute(Current)

University College London

London Cancer

CRUK Lung Cancer Centre of Excellence

Anna Mikolajczak is an author at The Francis Crick Institute specializing in cancer immunotherapy, tumor immunology, and interferon responses.

ORCID

Publications per year

2021–2025

5

Publications

5

A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer

Amelia Acha‐Sagredo, Pietro Andrei, Kalum Clayton et al. · Cancer Cell · 2025 · 51 citations · Full text

, , +14

Deep Learning Enables Spatial Mapping of the Mosaic Microenvironment of Myeloma Bone Marrow Trephine Biopsies

Yeman Brhane Hagos, Catherine S.Y. Lecat, Dominic Patel et al. · Cancer Research · 2023 · 14 citations · Full text

, , +16

Accelerated developmental adipogenesis programs adipose tissue dysfunction and cardiometabolic risk in offspring born to dams with metabolic dysfunction

Anna Mikolajczak, Nada A. Sallam, Radha Dutt Singh et al. · American Journal of Physiology-Endocrinology and Metabolism · 2021 · 12 citations · Full text

, , +16

Type I IFN drives neutrophil swarming, impeding lung T cell–macrophage interactions and TB control

William J. Branchett, Evangelos Stavropoulos, Jessica M. Shields et al. · The Journal of Experimental Medicine · 2025 · 12 citations · Full text

, , +17

Blimp-1 and c-Maf regulate immune gene networks to protect against distinct pathways of pathobiont-induced colitis

Marisol Alvarez-Martinez, Luke S. Cox, Claire Pearson et al. · Nature Immunology · 2024 · 11 citations · Full text

, , +17

1–5 of 5